DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Jim Clay :

Jim Clay

Senior Analytical Scientist, Kindeva Drug Delivery

Paper: Increased Sustainability Via the Use of Abbreviated Impactor Measurements (AIM) for Aerodynamic Particle Size Distribution (APSD) of Oral Pressurised Metered Dose Inhalers (pMDIs)

Jim is a Senior Analytical Scientist at Kindeva Drug Delivery in the UK.
After graduating with a degree in Applied Science and Forensic Measurement in 1998, Jim started his career in the pharmaceutical industry joining 3M Health Care Ltd, now Kindeva Drug Delivery, in 1999.
Throughout his career within the Inhalation Division, working predominantly within Analytical Research & Development, Jim has acquired extensive practical and theoretical knowledge of a large range of analytical techniques required for early phase and late stage development of Pressurized Metered Dose Inhalers (pMDIs) and Dry Powder Inhalers (DPIs).
Jim has enhanced his knowledge and expertise of OINDP whilst working on numerous feasibility studies and development programs.

Video of Jim Clay

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk